PITTSBURGH, Feb. 27,
2025 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS)
today announced that on February 24, 2025, its Board of
Directors approved a 2025 dividend policy of 48
cents ($0.48) per share and
declared a quarterly dividend of 12 cents ($0.12) for each issued and outstanding share
of the Company's common stock. The dividend is payable
on March 18, 2025, to shareholders of record at the close of
business on March 10, 2025. This marks the fifth consecutive
year the Company has paid a dividend.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a
global healthcare company uniquely positioned to bridge the
traditional divide between generics and brands, combining the best
of both to more holistically address healthcare needs globally.
With a mission to empower people worldwide to live healthier at
every stage of life, we provide access at scale, currently
supplying high-quality medicines to approximately 1 billion
patients around the world annually and touching all of life's
moments, from birth to the end of life, acute conditions to chronic
diseases. With our exceptionally extensive and diverse portfolio of
medicines, a one-of-a-kind global supply chain designed to reach
more people when and where they need them, and the scientific
expertise to address some of the world's most enduring health
challenges, access takes on deep meaning at Viatris. We are
headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more
at viatris.com and investor.viatris.com, and connect with
us
on LinkedIn, Instagram, YouTube and X (formerly
Twitter).
Forward-Looking Statements
This press release includes
statements that constitute "forward-looking statements." These
statements are made pursuant to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Such forward
looking statements may include statements regarding Viatris' 2025
dividend policy of 48 cents ($0.48) per share and Viatris declaring a
quarterly dividend of 12 cents ($0.12) for each issued and outstanding share
of the Company's common stock payable on March 18, 2025 to
shareholders of record at the close of business on March 10,
2025. Because forward-looking statements inherently involve risks
and uncertainties, actual future results may differ materially from
those expressed or implied by such forward-looking statements.
Factors that could cause or contribute to such differences include,
but are not limited to: actions and decisions of healthcare and
pharmaceutical regulators; our ability to comply with applicable
laws and regulations; changes in healthcare and pharmaceutical laws
and regulations in the U.S. and abroad; any regulatory, legal or
other impediments to Viatris' ability to bring new products to
market; Viatris' or its partners' ability to develop, manufacture,
and commercialize products; the scope, timing and outcome of any
ongoing legal proceedings, and the impact of any such proceedings;
Viatris' failure to achieve expected or targeted future financial
and operating performance and results; risks associated with
international operations; changes in third-party relationships; the
effect of any changes in Viatris' or its partners' customer and
supplier relationships and customer purchasing patterns; the
impacts of competition; changes in the economic and financial
conditions of Viatris or its partners; uncertainties and matters
beyond the control of management, including general economic
conditions, inflation and exchange rates; and the other risks
described in Viatris' filings with the Securities and Exchange
Commission (SEC). Viatris routinely uses its website as a means of
disclosing material information to the public in a broad,
non-exclusionary manner for purposes of the SEC's Regulation Fair
Disclosure (Reg FD). Viatris undertakes no obligation to update
these statements for revisions or changes after the date of this
press release other than as required by law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-maintains-dividend-policy-for-2025-and-announces-quarterly-dividend-302386556.html
SOURCE Viatris Inc.